Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

Transformation

Financiado

Understanding malignant transformation of precancerous lesions in human colon

A crucial milestone in tumor progression is the transformation from a benign adenoma to a malignant cancer, which has profound impact on clinical outcome and therapy design. Despite its importance, it is poorly understood why it m... ver más

30/04/2029

UMC UTRECHT

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-23

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2023-COG: ERC CONSOLIDATOR GRANTS

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

UMC UTRECHT

2.00M€ | Lider

Proyectos interesantes

SAF2008-01596 ES LA RESPUESTA A DAÑO EN EL ADN UNA BARRERA CONTRA EL CANCE... 227K€ Cerrado

SAF2010-21171 MECHANISMS OF ER-POSITIVE BREAST CANCER METASTASIS 206K€ Cerrado

BIO2015-71792-P EXPLORACION DE MUTACIONES SOMATICAS NO ALEATORIOS EN GENOMAS... 296K€ Cerrado

FJC2019-040379-I Estudio de la inestabilidad genómica en cáncer 50K€ Cerrado

BES-2017-081695 Genomic Instability and Cancer 93K€ Cerrado

PRE2018-083390 Genomic Instability and Cancer 93K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 60 meses Fecha Inicio: 2024-04-23
Fecha Fin: 2029-04-30

Líder del proyecto

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto A crucial milestone in tumor progression is the transformation from a benign adenoma to a malignant cancer, which has profound impact on clinical outcome and therapy design. Despite its importance, it is poorly understood why it manifests itself as a bottleneck that can restrain precancerous adenomas for years. While recent sequencing efforts inform ‘static’ insights into the status of cancer genomes, these are incomplete to infer how they evolved, assess functional consequence of mutations, nor how much malignancy is environmentally instructed. Practical limitations hamper scientific advancement into the dynamic nature of tumor evolution. Foremost, studying human tumor evolution is challenging as sequential sampling is not feasible, and pre-malignant events that may hold the clue for understanding transformation often occur years before cancer diagnosis. Moreover, experimental models that reflect malignant transformation, let alone of human origin, are lacking. TRANSFORMATION aims to resolve how human cancer genomes evolve towards malignancy, and its role in triggering malignancy. To gain new insights on this matter, TRANSFORMATION takes a unique approach to produce experimental insights into evolutionary parameters that are inherently dynamic in nature and cannot be obtained from tumor sequencing alone. Using paired biopsies from early-stage colon cancers, I generated unique organoid models from pre- and post-transformation regions. Together with in situ analysis of matched tumors, TRANSFORMATION will reveal the elusive rate and order by which mutations and copy-number alterations are acquired, the patterns by which cancer karyotypes evolve, dissecting functional from non-functional genetic heterogeneity on tumor phenotypes and investigate possible selection pressures imposed by environmental conditions. TRANSFORMATION will solve how colon tumors evolve pre-malignancy, which properties promote malignancy and why transformation is an evolutionary bottleneck.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores